Suchergebnisse
Suchergebnisse:
Sally Ann Kornbluth (* 1961) ist eine Zellbiologin, die seit Januar 2023 das Amt der 18. Präsidentin des Massachusetts Institute of Technology innehat. [1] Kornbluth war zuvor von 2014 bis 2022 Provost der Duke University und von 2006 bis 2014 Vizedekan für Grundlagenwissenschaften der Duke University School of Medicine. [2]
Sally Ann Kornbluth (born 1960) is an American cell biologist and academic administrator. She began serving as the 18th president of the Massachusetts Institute of Technology in January 2023.
Sally Kornbluth became MIT’s 18th president on January 1, 2023. She is a cell biologist whose eight-year tenure as Duke University’s provost earned her a reputation as a brilliant administrator, a creative problem-solver, and a leading advocate of faculty excellence and student wellbeing.
Sally Kornbluth is President of MIT. Before she closed her lab to focus on administration, her research focused on the biological signals that tell a cell to start dividing or to self-destruct — processes that are key to understanding cancer as well as various degenerative disorders.
20. Okt. 2022 · Sally A. Kornbluth, a cell biologist whose eight-year tenure as Duke University’s provost has earned her a reputation as a brilliant administrator, a creative problem-solver, and a leading advocate of academic excellence, has been selected as MIT’s 18th president. Kornbluth, 61, was elected to the post this morning by a vote of the MIT Corporation.
Sally Kornbluth is MIT's 18th president. Since she joined MIT in January 2023, President Kornbluth has fostered bold thinking – from solutions to dramatically accelerate progress against climate change, to helping ensure the power of AI is harnessed for good, to exploring daring new links between engineering and life science.
20. Okt. 2022 · October 20, 2022. Read story. Hearty congratulations and welcome to incoming MIT President Sally Kornbluth! As a cell biologist, Kornbluth’s research has focused on cell proliferation and programmed cell death, key processes in cancer and degenerative disorders.
